Related references
Note: Only part of the references are listed.TDM is dead. Long live TCI!
Nick Holford et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)
Therapeutic drug monitoring in inflammatory bowel disease reduces unnecessary use of infliximab with substantial associated cost-savings
Yang Wu et al.
INTERNAL MEDICINE JOURNAL (2021)
Therapeutic drug monitoring and pharmacogenetics of antipsychotics and antidepressants in real life settings: A 5-year single centre experience
Sara Baldelli et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2021)
Personalizing dosing of risperidone, paliperidone and clozapine using therapeutic drug monitoring and pharmacogenetics
Jose de Leon
NEUROPHARMACOLOGY (2020)
Safe administration of high-dose methotrexate with minimal drug level monitoring: Experience from a center in north India
Himani Dhingra et al.
PEDIATRIC BLOOD & CANCER (2020)
Therapeutic drug monitoring of tacrolimus in kidney transplantation
Shyam Bihari Bansal
INDIAN JOURNAL OF TRANSPLANTATION (2020)
An Indian national survey of therapeutic drug monitoring with anti-tumor necrosis (TNF) medications in inflammatory bowel disease
Rajan N. Patel et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2020)
Clinical utility of therapeutic drug monitoring of antiepileptic drugs Systematic review
Zanab Al-Roubaie et al.
NEUROLOGY-CLINICAL PRACTICE (2020)
Therapeutic Drug Monitoring of Oral Anticancer Drugs: The Dutch Pharmacology Oncology Group-Therapeutic Drug Monitoring Protocol for a Prospective Study
Stefanie L. Groenland et al.
THERAPEUTIC DRUG MONITORING (2019)
Therapeutic drug monitoring of vancomycin by AUC(tau)-MIC ratio in patients with chronic kidney disease
Ahmad Khoei et al.
RESEARCH IN PHARMACEUTICAL SCIENCES (2019)
Evolution of high-level resistance during low-level antibiotic exposure
Erik Wistrand-Yuen et al.
NATURE COMMUNICATIONS (2018)
Reference ranges for antiepileptic drugs revisited: a practical approach to establish national guidelines
Arne Reimers et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
An overview of the antimicrobial resistance mechanisms of bacteria
Wanda C. Reygaert
AIMS MICROBIOLOGY (2018)
Recommendations for Optimizing Tuberculosis Treatment: Therapeutic Drug Monitoring, Pharmacogenetics, and Nutritional Status Considerations
Rihwa Choi et al.
ANNALS OF LABORATORY MEDICINE (2017)
Utilization of alternative systems of medicine as health care services in India: Evidence on AYUSH care from NSS 2014
Shalini Rudra et al.
PLOS ONE (2017)
Personalized medicine could transform healthcare
Sunil Mathur et al.
BIOMEDICAL REPORTS (2017)
Essential medicines for cancer: WHO recommendations and national priorities
Jane Robertson et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2016)
Therapeutic Index Estimation of Antiepileptic Drugs: A Systematic Literature Review Approach
Rachel G. Greenberg et al.
CLINICAL NEUROPHARMACOLOGY (2016)
Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychotics
Edoardo Spina et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Therapeutic drug monitoring in anti-tuberculosis treatment: a systematic review and meta-analysis
L. Mota et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2016)
Directional reflectance analysis for identifying counterfeit drugs: Preliminary study
Slawomir Wilczynski et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2016)
An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs
Shery Jacob et al.
DRUGS IN R&D (2016)
Antibiotic Resistance in India: Drivers and Opportunities for Action
Ramanan Laxminarayan et al.
PLOS MEDICINE (2016)
Therapeutic drug monitoring of antimicrobials
Indran Balakrishnan et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2016)
Therapeutic Drug Monitoring of Antiepileptic Drugs in a Tertiary Care Hospital in India
Natarajan Harivenkatesh et al.
CLINICAL NEUROPHARMACOLOGY (2015)
How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?
Gloria Wong et al.
BMC INFECTIOUS DISEASES (2014)
Therapeutic drug monitoring in cancer - Are we missing a trick?
Christophe Bardin et al.
EUROPEAN JOURNAL OF CANCER (2014)
Guidelines for Therapeutic Drug Monitoring of Vancomycin: A Systematic Review
Zhi-Kang Ye et al.
PLOS ONE (2014)
Phenytoin: A Guide to Therapeutic Drug Monitoring
Melissa Faye Wu et al.
PROCEEDINGS OF SINGAPORE HEALTHCARE (2013)
Therapeutic drug monitoring of antimicrobials
Jason A. Roberts et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Drug Interactions with Herbal Medicines
Shaojun Shi et al.
CLINICAL PHARMACOKINETICS (2012)
Experience with high dose methotrexate therapy in childhood acute lymphoblastic leukemia in a tertiary care cancer centre of a developing country
Gauri Kapoor et al.
PEDIATRIC BLOOD & CANCER (2012)
Toxicities of Immunosuppressive Treatment of Autoimmune Neurologic Diseases
Enrico C. Lallana et al.
Current Neuropharmacology (2011)
Therapeutic Drug Monitoring of Protease Inhibitors and Efavirenz in HIV-Infected Individuals With Active Substance-Related Disorders
Qing Ma et al.
THERAPEUTIC DRUG MONITORING (2011)
Therapeutic drug monitoring in a developing country: an overview
N. J. Gogtay et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Use of therapeutic drug monitoring of cancer chemotherapy to modify initial per-protocol doses
J. Rebollo et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Therapeutic Drug Monitoring of Lithium in Patients With Bipolar Affective Disorder: Experiences From a Tertiary Care Hospital in India
Sangeeta Sharma et al.
AMERICAN JOURNAL OF THERAPEUTICS (2009)
Overview of Therapeutic Drug Monitoring
Ju-Seop Kang et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2009)
Antiepileptic drugs - best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies
Philip N. Patsalos et al.
EPILEPSIA (2008)
Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections
Peggy S. McKinnon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Herbal supplements and therapeutic drug monitoring: Focus on digoxin immunoassays and interactions with St. John's wort
Amitava Dasgupta
THERAPEUTIC DRUG MONITORING (2008)
Malnutrition and infection: Complex mechanisms and global impacts
Ulrich E. Schaible et al.
PLOS MEDICINE (2007)
A retrospective TDM database analysis of interpatient variability in the pharmacokinetics of lopinavir in HIV-infected adults
Martijn R. van der Leur et al.
THERAPEUTIC DRUG MONITORING (2006)
Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana
JW Tappero et al.
CLINICAL INFECTIOUS DISEASES (2005)
Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals
D Burger et al.
AIDS (2003)
Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine
M Weiner et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Pharmacodynamics of cefepime in patients with Gram-negative infections
VH Tam et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Therapeutic drug monitoring of inununosuppressant drugs in clinical practice
BD Kahan et al.
CLINICAL THERAPEUTICS (2002)
A pharmacoeconomic analysis of the impact of therapeutic drug monitoring in adult patients with generalized tonic-clonic epilepsy
CT Rane et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Genetic polymorphisms in drug-metabolizing enzymes and drug targets
M Hiratsuka et al.
MOLECULAR GENETICS AND METABOLISM (2001)
Share Paper
